|
AB ☆ India, 2013-01-10 09:42 (4913 d 12:52 ago) Posting: # 9811 Views: 4,183 |
|
|
Dear All, Can we adopt a ref scaling approach in a steady state design for highly variable drugs? if yes, in such cases what are the parameters to consider for the scaling for USFDA & EMA submission studies. Many thanks in advance. — Regards, AB |
|
Helmut ★★★ ![]() Vienna, Austria, 2013-01-10 14:30 (4913 d 08:04 ago) @ AB Posting: # 9814 Views: 3,621 |
|
|
Dear AB, ❝ Can we adopt a ref scaling approach in a steady state design for highly variable drugs? Why not? ❝ if yes, in such cases what are the parameters to consider for the scaling for USFDA & EMA submission studies. Not sure what you mean by “parameters to consider for the scaling”.
— Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
|
AB ☆ India, 2013-01-11 14:42 (4912 d 07:53 ago) @ Helmut Posting: # 9825 Views: 3,384 |
|
|
Dear Helmut, Many thanks for your response. “parameters to consider for the scaling”. I mean which PK parameters to consider for the scaling. Along with PK parameters and criteria you mentioned, should we also consider Cmin for scaling or not? am not sure to what extent my question is valid. Thanks again — Regards, AB |
|
Helmut ★★★ ![]() Vienna, Austria, 2013-01-11 15:11 (4912 d 07:24 ago) @ AB Posting: # 9826 Views: 3,472 |
|
|
Dear AB! ❝ Along with PK parameters and criteria you mentioned, should we also consider Cmin for scaling or not? According to the guidance you should report Cmin together with Cav, degree of fluctuation [(Cmax–Cmin)/Cav], and swing [(Cmax–Cmin)/Cmin]. A statistical comparison is not required.— Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |

![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
![[image]](https://static.bebac.at/img/CC by.png)
guidance